Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Washington
M.D. Anderson Cancer Center
Medical College of Wisconsin
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Medical College of Wisconsin
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
Children's Hospital Medical Center, Cincinnati
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Therapeutic Advances in Childhood Leukemia Consortium
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Northwestern University
Nanfang Hospital, Southern Medical University
Memorial Sloan Kettering Cancer Center
Medical College of Wisconsin
City of Hope Medical Center
University of Nebraska
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
University of Washington
M.D. Anderson Cancer Center
University of Kentucky
Washington University School of Medicine
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Washington